StockWatch
·

SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q2 FY26 Results

SPARCQ2 FY26 Results
Filing
MetricValue (₹ Cr)Q1 FY26Q2 FY25
Revenue7.8618.5%38.9%
Total Income7.8758.1%39.0%
Expenditure83.6618.5%30.3%
PBT-75.7946.3%29.3%
Net Profit-75.8546.2%29.3%
OPM—
NPM—
EPS2.3446.3%170.7%
View full financials

Informational and educational content only. Not investment advice.